A Electron densities and neutron scattering length densities of the stabilizer molecules and DNA For the electron densities (EDs) ρ X and neutron scattering length densities (NSLDs) ρ n of the shells physically meaningful range specifications were imposed in the fits: Lecithin molecules possess a distinct contrast between their phosphocholine head groups (without additional water molecules: ρ X = 514 nm −3 , ρ n = 1.88 · 10 −6 Å −2 [1] ) and their acyl chains (depending on the degree of unsaturation and length, typically ρ X = 270 . . . 280 nm −3 , ρ n = −0.1 · 10 −6 . . . − 0.4 · 10 −6 Å −2 [1, 2] ). For a DODAB molecule ( Fig. 1(e) ), similar values for the EDs and NSLDs for the acyl chains (18:0) and head group are found. The contrast between the hydrophilic PEG (ρ X = 350 nm −3 , ρ n = 0.60 · 10 −6 Å −2 ) and hydrophobic PPG blocks (ρ X = 332 nm −3 , ρ n = 0.34 · 10 −6 Å −2 ) in PLX ( Fig. 1(c) ) is much lower. For TW ( Fig. 1(d) ), with its monooleate (18:1) chain and a head group consisting of 20 PEG blocks partitioned onto 4 branches, the EDs and NSLDs are nearly the same as for the lecithin chains and pure PEG blocks. The ED for DNA (without further water molecules) is about 540 nm −3 and thus on the order of the lecithin head groups.
The NSLD is about 4 · 10 −6 Å −2 in D 2 O. D 2 O at 25 • C has ρ X = 333 nm −3 and ρ n = 6.3 · 10 −6 Å −2 .
Usually the inner shell is dedicated for the lipophilic parts of the stabilizer molecules (in this study: fatty acid residues for S100, DODAB and TW; PPG blocks for PLX) and the outer shell for their hydrophilic parts (phosphocholine head groups for S100, dimethylammonium head group for DODAB and essentially PEG blocks for TW and PLX) and the DNA. However, such a separation is quite difficult in the present study because of the different structures of the molecules. While S100, DODAB and TW share a certain similarity in their acyl chain and head group (on average TW's head groups are only 5 PEG units long) lengths, the situation for S100, DODAB and PLX is different. PLX is expected to adopt a U-conformation with the PPG blocks being flatly condensed at the nanocrystal surfaces. But the two hydrophilic 80-PEG-units-long branches are structurally very different to the rather small head groups of DODAB and S100 and might protrude much farther into the dispersion medium. Furthermore for the complexes, it cannot be ruled out that the sandwiched DNA partially penetrates into the inner shell. Thus the concept to separate the stabilizer's lipophilic parts into the inner shell and its hydrophilic parts (plus the DNA) into the outer shell may oversimplify the problem. A reliable differentiation between the individual stabilizer molecules and the DNA in such complicated mixtures is challenging (e.g. similar ED and NLSD for chains of DODAB and S100; similar EDs for the lecithin head group and DNA). Thus, in the fits, the range of EDs and NSLDs in both shells was set to the minimum and maximum values of the EDs and NSLDs of the involved molecules and dispersion medium: 270 . . . 540 nm −3 for the EDs and −0.5 · 10 −6 . . . 6.3 · 10 −6 Å −2 for the NSLDs.
B Trimyristin suspensions

B.1 Native trimyristin suspensions
Native trimyristin (MMM, Dynasan ® 114, 98%, Sasol GmbH, Witten, Germany) suspensions were prepared to screen for stable suspensions whose colloidal platelets can form sandwich-like assemblies with DNA. The aqueous suspensions were prepared from MMM (10%) and stabilized by the lecithin blend S100 (2.4%) and different types and amounts of cationic stabilizers. We use the abbreviation y -x, where y denotes the different cationic stabilizers: Dimethyldioctadecylammonium bromide (DODAB, 98%, Fig. S1 (a), Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany), Dioleoyltrimethylammonium propane (DOTAP, Fig. S1 (b), Lipoid AG, Ludwigshafen, Germany), Cetylpyridinium chloride (CPYC, 99%, Fig. S1 (c), Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany), and those of the alkyltrimethylammonium bromide series: C 6 TAB (98%, Fig. S1 (g)), C 10 TAB (99.9%, Fig. S1 (f)), C 12 TAB (98%, Fig. S1 (e)) (all from TCI Deutschland GmbH, Eschborn, Germany) and C 16 TAB (98%, Fig. S1 Figure S1 : Molecular structures of the stabilizers used in the study of the MMM suspensions.
All cationic stabilizers are quaternary ammonium compounds. They differ in their head group and the number, length and degree of unsaturation of their hydrophilic carbon chains. The single-tailed C 6 TAB, C 10 TAB, C 12 TAB, C 16 TAB of the alkyltrimethylammonium bromide series share the same head group and differ only in their chain lengths. CPYC has the same chain length as C 16 TAB, but has a pyridinium head group. The double-tailed surfactant DOTAP shares the same chain length with DODAB, but has mono-unsaturated chains.
B.1.1 Preparation of the native MMM suspensions
MMM and S100 were heated to 65 • C until a clear yellowish melt was obtained. H 2 O was heated to the same temperature. While the surfactants DODAB and DOTAP were mixed with the melt, CPYC and the cationic surfactants of the alkyltrimethylammonium bromide series were dissolved in H 2 O. The hot mixture was pre-dispersed for 3 minutes with an Ultra-Turrax T25 Basic disperser (IKA-Werke GmbH & Co. KG, Staufen, Germany) at 22.000 rpm. 1 ml of the hot MMM pre-emulsion was filled into a reaction tube. An MS 73 ultrasonic needle of a Sonopuls ultrasonic homogenizer (Bandelin electronic, Berlin, Germany) was immersed to a maximum depth of 2 cm in the pre-emulsion, avoiding any contact with the surrounding reaction tube, and the pre-emulsion was sonicated for 5 min in a pulsed mode. Formulations with 0.4% cationic stabilizers (CPYC, C 10 TAB, C 12 TAB, C 16 TAB), which upon ultrasonication and crystallization provided stable suspensions with PCS measured z-averages for the hydrodynamic diameters below 250 nm, were further considered. The formulations with C 6 TAB, DODAB and DOTAP solidified. Table SI : z-averaged hydrodynamic particle diameters (d PCS ) and polydispersity indices (PdI) for native MMM suspensions. Furthermore, the enthalpies of fusion (∆H fus ) and crystallization (∆H cry ), derived from the µDSC heating and cooling runs in Fig. S2(a) To obtain smaller particle sizes, the hot MMM pre-emulsions of three successful candidates (CPYC, C 12 TAB, C 16 TAB with 0.4% and 1.2% cationic stabilizer) were passed to an APV-2000 high-pressure melt homogenizer (APV Deutschland GmbH, Unna, Germany) which was preheated to a temperature of about 70 • C. About 40 ml of the samples were homogenized in a closed loop for four minutes with gradually increasing pressures between 1 and 1.5 kbar. The MMM nanoemulsions were allowed to cool down to room temperature and finally stored in crimped glass vials at 6 • C. In contrast to tripalmitin nanoemulsions, which crystallize above room temperature, cooling below 10 • C is crucial to crystallize MMM nanoemulsions, because of a strong super-cooling effect for triglyceride nanoemulsions [3] . The crystallization of triglyceride emulsion droplets into the thin platelets of the stable β-modification is accompanied by a vigorous surface expansion. To cover quickly the newly created surfaces of the platelets, it is assumed that highly mobile co-stabilizers are required, to prevent a gelation [4] . The double-tailed surfactants DODAB and DOTAP are too slow to stabilize the nanoparticles upon crystallization. The single-tailed cationic surfactants can diffuse faster. The reason why C 6 TAB cannot stabilize the dispersion successfully is not yet understood.
B.1.2 PCS measurements
The z-averaged hydrodynamic diameters d PCS and the corresponding polydispersity indices of the selected native MMM suspensions are listed in Tab. SI. All suspensions possess polydisperse particle size distributions. The d PCS -values, which can be regarded as a rough estimate of the platelet diameters, vary between about 120 and 150 nm. The size distributions show moderate polydispersity indices between 0.14 and 0.21.
B.1.3 µDSC measurements
The DSC heating and cooling curves of the MMM dispersions are visualized in Fig. S2(a) . Between about 26 • C and 56 • C (melting point of bulk MMM) many partially overlapping melting peaks can be observed in the heating curve. For temperatures between 35 and 56 • C these peaks can be attributed to the melting of platelets in the β-modification (dashed box labelled by β), where each peak corresponds to the melting of platelets with a specific thickness [5] . In particular for the CPYC and C 16 TAB stabilized suspensions between 29 and 34 • C another broad melting peak can be observed. Increasing the concentration of CPYC and C 16 TAB from 0.4% to 1.2%, the fraction of the enthalpy of fusion of this pre-transition ∆H * fus (integrated in the range 26 -35 • C, dashed box with the question mark) with respect to the total enthalpy of fusion ∆H fus (integrated over the full heating run) rises by a factor of more than 2 (Table SI) . For the C 12 TAB stabilized suspensions this pre-transition is much weaker and does not change with C 12 TAB concentration. Such pre-transitions can be attributed to a melting of cLNP adopting the thermodynamically metastable α-modification of MMM (bulk m.p. 33 • C [6] ) or to a fraction of smaller platelets with an unknown MMM modification, as it was reported for tyloxapol stabilized MMM suspensions with a pre-transition between 30 • C and 38 • C [7] . . Furthermore, their peak is preceded and followed (again at about 11.5 • C) by small shoulders. The higher crystallization temperatures for C 16 TAB-1.2 and CPYC-1.2 can be explained by the increased chain length and higher concentration of their cationic stabilizers. Stabilizers with longer saturated alkyl chains can increase the crystallization temperature of emulsion droplets, as it was shown for lecithin stabilized triglyceride dispersions [8] .
B.1.4 SAXS measurements
The SAXS patterns of the MMM suspensions and their cLNP-DNA complexes were measured with a Kratky camera (S3-MICROpix, Hecus X-Ray Systems GmbH, Graz, Austria) at FRM II in Garching, Germany. The 50 W Cu K α (λ = 1.54 Å) microfocus X-ray source (Xenocs, Sassenage, France) was equipped with a 3D single bounce mirror optics, focusing the primary beam into the detector plane. The collimator was adjusted to deliver a beam of about 0.25 × 0.25 mm 2 at the sample position, leading to a total flux of about 10 7 photons/s. The samples and water were measured in a reusable quartz capillary with an inner diameter of about 1 mm. Exposures were taken at 25 • C for one hour with a Pilatus 100K detector (Dectris AG, Baden, Switzerland). The sample-detector distance of 289.5 mm was calibrated with a silver behenate standard (Eastman Kodak Company). A secondary standard (glassy carbon [9] ) was used to put the scattered intensities on an absolute scale. The SAXS patterns of the native MMM suspensions are visualized in Fig. S2 (b). At s = 0.280 nm −1 the SAXS patterns feature the 001 Bragg reflection of MMM nanocrystals in the β-modification [10] . Since the platelets possess a thickness of only a few molecular layers of MMM, the 001 Bragg peak is strongly broadened. In particular for CPYC-1.2 and C 16 TAB-1.2 the Bragg peak becomes asymmetric. This could be associated with a Bragg reflection, stemming from the unknown MMM modification. For all suspensions, the diffuse small-angle scattering intensity is super-imposed by at least three peaks, indicating a lamellar order in the dispersion (for C 12 TAB-1.2 labelled by 1, 2 and 3 in Fig. S2(b) ). These additional reflections can be attributed to a self-assembly of the triglyceride platelets into stacks [11, 12] . The platelet repeat distances in these stacks range between 40 and 50 nm for the different suspensions.
B.2 MMM-DNA complexes
cLNP-DNA complexes were prepared from the MMM suspensions CPYC-x, C 16 TAB-x, C 12 TAB-x with charge ratios ξ between ∞ (no DNA) and 0.3 and final MMM concentrations of 1% or 3% MMM. cLNP-DNA complexes with low charge ratios (0.3, 0.5, 0.7 and 1) often solidified or larger agglomerates became visible. For the same charge ratios, cLNP-DNA complexes prepared from native suspensions with 1.2% of the cationic stabilizer tend to agglomerate more easily compared to those with only 0.4%, probably because the total amount of added DNA is three times higher in the former dispersions. Fig. S3(a) . ∆H † fus and ∆H † cry denote the enthalpy of fusion and crystallization associated with the melting of large platelet agglomerates observed in the dashed boxes in Fig. S3(a) . 
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B.2.2 µDSC measurements
The increased agglomeration of the platelets with decreasing charge ratio manifests also in the microcalorimetric heating and cooling runs. As an example, for cLNP-DNA complexes prepared from CPYC-1.2 (3% MMM), the heating and cooling runs are visualized in Fig. S3(a) . Upon addition of DNA, a new melting peak arises in the heating scans around the melting point of bulk MMM (56 • C). The integral intensity of this peak rises with decreasing charge ratio. The corresponding melting event can be attributed to the melting of (macroscopic) cLNP-DNA complexes consisting of many platelets. The calculated enthalpies of fusion ∆H fus for all melting events and ∆H † fus for the peak at 56 • C (integrated in the range 52 -56 • C, dashed box in the heating run of Fig. S3(a) ) are listed in Table SII(b) . For the highest DNA loading (ξ = 0.3) only large agglomerates are present and no melting peaks of small complexes and remaining individual platelets (temperatures below the dashed boxes) can be observed anymore. A similar conclusion can be drawn from the cooling curves. Upon addition of DNA the main crystallization peak around 14.6 • C of the super-cooled single emulsion droplets is preceded for charge ratios >0.3 by additional exothermal peaks above 30 • C. The fraction of the enthalpies ∆H † cry of these crystallization events (integrated between 30 and 56 • C, dashed box in the cooling runs of Fig. S3(a) ) with respect to the total enthalpy of crystallization ∆H cry (integration over all crystallization events in the cooling runs) rise with decreasing charge ratio ( agreement (Fig. S4) . Thus, these crystallization peaks correspond to the crystallization of larger molten cLNP-DNA agglomerates. For the charge ratio 0.3 any crystallization of molten single platelets or small complexes is missing and the large molten agglomerates recrystallize already between 43.5 • C and 35 • C.
B.2.3 TEM micrograph
Agglomerates of several platelets were found in freeze-fracture TEM micrographs of cLNP-DNA complexes prepared from CPYC-0.4 with the charge ratio 3 (cf. Fig. S5 ). The micrograph suggests a stack-like agglomeration of the platelets. However, as it is demonstrated below, the SAXS patterns of these DNAcomplexes can clearly rule out this possibility. The MMM platelets possess an elongated shape with lengths of the long axis ranging typically between 200 and 500 nm.
B.2.4 SAXS measurements
The SAXS patterns for cLNP-DNA complexes (3% MMM), prepared from the native suspensions CPYCx, C 16 TAB-x and C 12 TAB-x with a charge ratio ξ = 1, are shown in Fig. S3(b) . They do not clearly feature distinct peaks of a lamellar order. Nevertheless, in the s-range between the diffuse small-angle scattering (s < 0.06 nm −1 ) and the 001 Bragg peak (s > 0.22 nm −1 ), for the complexes prepared from native suspensions with 0.4% of the cationic stabilizer, a broad bump with additional small peaks on top is observed. For complexes prepared from the native suspensions with 1.2% cationic stabilizer a more distinct peak (marked by an arrow) appears at s = 0.17 nm −1 (CPYC-1.2, C 12 TAB-1.2) and s = 0.16 nm −1 (C 16 TAB-1.2), respectively. As there is no clear indication of a lamellar order in the SAXS patterns, it can be concluded that the tested suspensions cannot form complexes with a sandwich-like structure of the platelets and DNA. It is demonstrated below in section C.3, that the SAXS patterns in Fig. S3(b) resemble in the considered s-range those of DNA-complexes prepared with triglyceride-free dispersions, containing only the cationic and nonionic stabilizers. This indicates that the DNA induces a dissociation of the cationic and lecithin molecules from the surface of the platelets and forms complexes with these lipids, while the platelets, being (partially) deprived of their stabilizer molecules, agglomerate in a non-stacked way. The comparison between the TEM and the SAXS data suggests that freeze-fracture TEM micrographs of such DNA-complexes should be regarded with care. Agglomerates of such platelets could be misleadingly interpreted as complexes with a stacked structure of the platelets. SAXS allows a more reliable differentiation between agglomerates with and without a stacked arrangement of the platelets. This is because, platelet stacks would cause pronounced lamellarly ordered interference peaks in the SAXS patterns, as it is demonstrated for the DNA-complexes with the tripalmitin suspensions in the main article. Furthermore, in contrast to cryo-TEM and freeze-fracture TEM, no particular sample preparation is required for SAXS, and the suspensions can be measured in their native state at ambient temperatures. Figure S6 : Fractions of macroscopic cLNP-DNA complexes with respect to the total dispersed phase as determined by µDSC for complexes prepared with different charge ratios ξ from PLX-0.4, PLX-1.2 and TW-2.5. The data was taken from Table SIV. 102.0 0.26 n/a n/a n/a n/a TW-2. The influence of the lecithin stabilizer on the morphology of the cLNP and the internal structure of the nanocomposites was investigated. For this purpose, the lecithin blend S100 in the native suspensions was substituted by an equivalent amount of the fully saturated lecithin DMPC. The obtained suspensions are stable and provided for the TW-x series very similar particle size distributions as for the S100-stabilized suspensions (Table SV) . The size distributions for the PLX-x series are again less broad and indicate larger particles, compared to the dispersions of the TW-x series.
C Tripalmitin suspensions
(a) Native PPP PLX-x suspensions with DMPC or S100 (b) Native PPP TW-x suspensions with DMPC or S100 can be linked to the unknown PPP modification, the second section up to 66 • C to the β-modification.
As for the S100-stabilized suspensions, the amount of the enthalpy of fusion in the first section ∆H * fus (integrated in the dashed box marked with the question mark, 30 to 50 • C (PLX-x) or 48 • C (TW-x)) grows with rising DODAB concentration at the expense of the second section, and the melting peak shifts slightly to higher temperatures. The relative amount of the unknown PPP modification ∆H * fus /∆H fus is listed for all native PPP suspensions in Table SV and visualized in Fig. 10 in the article. For the DMPCstabilized dispersions, ∆H * fus /∆H fus is even for low concentrations of DODAB (TW-0.4 and PLX-0.4) much higher than for those with S100. For higher DODAB concentrations, the fraction increases to more than 70% for TW-2.5. Thus, from the WAXS and micro-calorimetric data, it is apparent that not only DODAB, but also DMPC with its two saturated acyl chains promotes the formation of the unknown PPP modification. The main crystallization peaks for the TW-x and PLX-x samples are in the range between 25 • C and 26 • C (cf. Fig. S8 ) and, thus, at very similar temperatures as for the suspensions prepared with S100 and high amounts of DODAB (PLX-1.2, PLX-2.0, TW-1.6 and TW-2.5 in Fig. 4 in the main article). All cooling curves in Fig. S8 , even those with very low amounts of DODAB (PLX-0.4, TW-0.4), exhibit one or more pre-crystallization events (those with the highest temperature are marked by arrows). Their highest onset temperatures rise with the amount of DODAB from 43.6 • C (PLX-0.4) to 48.1 • C (PLX-2.0) and from 37.6 • C (TW-0.4) to 49.0 • C (TW-2.5), respectively. The temperatures of these pre-crystallization events are generally higher than in the case of S100. Similarly to the S100-stabilized suspensions these pre-transitions can be most probably attributed to a pre-crystallization of the saturated acyl chains of the DODAB and here additionally, DMPC molecules at the surface of the emulsion droplets. For DMPCstabilized PPP suspensions similar pre-transitions were found starting at 40 • C [8] , in good agreement with the temperatures of 43.6 • C (PLX-0.4) and 37.6 • C (TW-0.4), found here for DMPC-stabilized suspensions with small concentrations in DODAB. The SAXS patterns of the native DMPC-stabilized suspensions are visualized in Fig. S9(a) . Particularly, in the range between the 001 Bragg peak and the diffuse small-angle scattering, the SAXS patterns of the PLX-x series, TW-0.4 and TW-0.8 differ from those of their S100-stabilized counterparts (cf. Fig. 5a in the article). A bump at s b = 0.084 nm −1 for the PLX-x series (marked with B 1 in Fig. S9(a) ), and, more pronounced for the TW-x series at 0.090 nm −1 (marked with B), is found (positions s b listed in Table SIII ). For TW-1.6 and TW-2.5 the scattering patterns and the positions of B are very similar to those of the corresponding S100-stabilized suspensions. For the suspensions of the PLX-x series an additional small peak (marked with B 2 in Fig. S9(a) ) can be observed in the s-range between 0.13 and 0.135 nm −1 , and thus, at a similar position as the bump in the S100-stabilized suspension of the PLX-series, TW-0.4 and (Table SIII) are nearly the same as in the case of the S100-stabilized versions of PLX-x, TW-1.6 and TW-2.5. For TW-0.4 and TW-0.8 which exhibited the largest increase in the unknown PPP modification with its small platelets, the 001 Bragg peak is shifted to lower s and became broader than for the corresponding suspensions with S100. The differences in the SAXS patterns of the native DMPC-stabilized suspensions of the PLX-x series, TW-0.4 and TW-0.8 with respect to their S100-stabilized counterparts already indicate different structures for their cLNP-DNA complexes. Indeed, all SAXS patterns of the cLNP-DNA complexes (3% PPP), prepared from the DMPC-stabilized suspensions, exhibit stack-related interferences, associated with repeat distances between of 11.1 and 11.9 nm, respectively (cf. Fig. S9 and Table SIII) . Again, the repeat distances decrease slightly with increasing amount of DODAB (from 11.9 nm (PLX-0.4, TW-0.4) to 11.4 nm (PLX-2.0) and 11.1 nm (TW-2.5)). Interestingly, in the SAXS patterns of the complexes prepared from the native PLX-x suspensions (Figs. S9(b), S9(c) and S9(d)), the second bump B 2 is still present (in particular for PLX-1.2 and PLX-2.0 and at charge ratios close to the isoelectric point, 0.7 and 1). But, in contrast to the SAXS patterns of their S100-stabilized counterparts, almost no lamellar order, corresponding to a repeat distance of about 15 nm can be found. Thus, it the thicker β-PPP platelets, which are most probably linked to the bump B 2 and caused repeat distances of about 15 nm in the case of the complexes of S100-stabilized PLX-x suspensions, are less frequently integrated into stacks as the smaller and thinner ones of the unknown PPP modification, which are most probably linked to the bump B 1 and form the stacks with repeat distances between 11 and 12 nm. For complexes from PLX-1.2 and PLX-2.0 with charge ratios around the isoelectric point, a small amount of the thicker platelets forms additional stacks with repeat distances of about 15 nm, since B 2 is enhanced by an interference between the scattering from B 2 and the stackrelated scattering. For the complex prepared from PLX-1.2 with the charge ratio 0.7 even a small first order reflection at s = 0.068 nm −1 (corresponding to d st = 14.7 nm) of this stack-related scattering can be found (marked by arrows in Fig. S9(c) ; the second order coincides with the position of B 2 ). The positions s b of the observed bumps B (B 1 and B 2 ) in the scattering patterns of the native S100-and DMPC-stabilized suspensions (Figs. 5(a) and S9(a)), which are most probably linked to the form factor or an unknown internal structure of the platelets, are clearly correlated to the amount of the unknown PPP modification and the repeat distance of the platelets in the cLNP-DNA complexes. As shown in Fig. S10 and Fig. 10 in the main article, a repeat distance of about 15 nm is always linked to a bump position between 0.11 and 0.13 nm −1 in the SAXS patterns and a fraction 40% of the unknown PPP modification for the dispersed PPP. By contrast, native suspensions with 55% of the unknown PPP modification feature bumps located between 0.083 and 0.092 nm −1 and produce always cLNP-DNA complexes with repeat distances between about 11 nm and 12 nm. For the transitional range between 40 and 55%, the native suspensions feature both bumps but their nanocomposites consist predominantly of the thinner platelets of the unknown PPP modification, since the intensity of the stack-related maxima, associated with repeat distances between 11 and 12 nm, prevails the peak intensities of stacks with repeat distances of about 15 nm (if they exist at all). Table SIII ). Native PPP suspensions stabilized by S100 (left) or DMPC (right), PLX or TW, and different DODAB concentrations were studied. For the S100-stabilized PLX-1.2 and PLX-2.0 suspensions, where no bump was directly visible in the SAXS patterns, and its existence manifested only in the SAXS patterns of their cLNP-DNA complexes, the same value for s b was used as for the S100-stabilized PLX-0.4 suspension (diagonally striped bars). For the DMPC-stabilized suspensions of the PLX-x series two bump positions were observed (filled bars for B 1 and chequered bars for B 2 ). The repeat distance of 14.7 nm (chequered bars in the upper part), present only marginally for some charge ratios of the complexes of the DMPC-stabilized PLX-1.2 and PLX-2.0 suspensions, were detected indirectly by an enhancement of the bump B 2 in the SAXS patterns of Figs. S9(c) and S9(d). 
C.2 XNPPSA Fits
C.3 Suspensions without PPP
Dispersions equivalent to PLX-0.4 and TW-2.5, but without PPP, were prepared by high-pressure homogenization and, along with their DNA-complexes, studied by SAXS. In Fig. S13(a) , the SAXS patterns for the native suspension PLX-0.4 and its cLNP-DNA complexes, as well as the patterns for their PPP-free counterparts are visualized. The native, PPP-free PLX-0.4 suspension exhibits four broad peaks at 0.083, 0.14, 0.195, and 0.256 nm −1 (marked by arrows) on top of a broad bump, stretching from about 0.055 to 0.30 nm −1 . From the SAXS patterns alone, it is difficult to draw definite conclusions on the structures causing these peaks. The broad underlying bump is most probably related to the characteristic form factors of lecithin and DODAB bilayers, which are typically found in a similar s-range [13] . The four peaks do not fit very well to a lamellar order. The two curves on the top correspond to the native suspensions without DNA. For the complexes, the native dispersions were diluted by a factor of 10, the charge ratios range from 0.5 to ∞. For clarity the curves were shifted vertically.
(a) Figure S14 : SAXS patterns (Hecus camera) for cLNP-DNA complexes (3% MMM, ξ = 1) prepared from the MMM suspensions CPYC-0.4 ( ) and CPYC-1.2 ( ). The SAXS patterns (A2 beamline) for the PPP-free, native suspension PLX-0.4 ( ) and cLNP-DNA complexes prepared from the PPP-free suspensions PLX-0.4 and TW-2.5 (10-fold dilution from the native suspensions) at a charge ratio ξ = 1 ( and , respectively) are shown, too. For clarity the curves were shifted vertically.
respectively (the SAXS patterns for the cLNP-DNA complexes prepared from CPYC-0.4 and CPYC-1.2 are representative for the patterns of the cLNP-DNA complexes with C 16 TAB and C 12 TAB (Fig. S3(b)) ).
For the cLNP-DNA complexes from CPYC-0.4, the broad bump with its small peaks on top (marked by black arrows) in the s-range 0.06 -0.22 nm −1 exhibits a certain similarity to the pattern of the PPP-free PLX-0.4 suspension. For higher amounts of CPYC and DNA (complexes prepared from CPYC-1.2), the single broad peak (marked by an arrow) might stem from multilamellar structures of S100 or a mixture of S100 and CPYC (repeat distance 5.9 nm), similarly as it was found for the PPP-free DNA-complexes from the PPP-free PLX-0.4 and TW-2.5 suspensions, which exhibit a peak at slightly smaller s-values. Thus, addition of DNA to the MMM suspensions might lead to a partial detachment of the S100 and singletailed cationic surfactant (CPYC, C n TAB) molecules from the MMM platelets. The released stabilizer molecules might form similar lipid or lipid-DNA structures as in the triglyceride-free dispersions while the MMM platelets agglomerate in a non-stacked arrangement due to an adsorption of the DNA or a lack of stabilizer molecules on their surfaces. In the case of the studied PPP suspensions which are stabilized by a blend of S100, the double-tailed, cationic surfactant DODAB and PLX / TW, the PLX and TW molecules which are crucial to inhibit a gelation of the native suspensions upon crystallization might also help to prevent such a release of stabilizer molecules upon interaction with the DNA and, thus, to facilitate the formation of such stacked nanocomposites.
